Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer

Defining biomarkers that predict therapeutic effects and adverse events is a crucial mandate to guide patient selection for personalized cancer treatments. In the present study, we applied a pharmacometabolomics approach to identify biomarkers potentially associated with pathological complete respon...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Miolo, Gianmaria, Muraro, Elena, Caruso, Donatella, Crivellari, Diana, Ash, Anthony, Scalone, Simona, Lombardi, Davide, Rizzolio, Flavio, Giordano, Antonio, Corona, Giuseppe
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129972/
https://ncbi.nlm.nih.gov/pubmed/27223427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9489
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars